PLATFORM PROFILENVO
Novo Nordisk
2.61
B-index (V3.1)
BLACK HOLE
Capture1.131
Escape0.434
Key Structural Insight
GLP-1 leader, insulin scale
Eleven-Parameter Profile
Data Depth7/10
Memory7/10
Action5/10
Process7/10
Network6/10
Closeness7/10
Portability4/10
Substitutability4/10
Human Fallback5/10
Org Depth8/10
Momentum5/10
Capture Escape Extended
V3.1 Decomposition
| Component | Value | Formula |
|---|---|---|
| CES₄ capture core | 0.6469 | CES(d, m, a, p) |
| Knowledge synergy σₖ | 0.7000 | √(d · m) |
| Operability synergy σₒ | 0.5916 | √(a · p) |
| Synergy boost | 1.1937 | 1 + 0.3·(σₖ + σₒ)/2 |
| Org-depth multiplier | 1.4000 | 1 + 0.5·o |
| Momentum multiplier | 1.1500 | 1 + 0.3·t |
| Total Capture | 1.1313 | c·(1+0.5n)·core·syn·org·mom |
| CES₃ escape core | 0.4321 | CES(x, s, h) |
| Feedback attenuation | 0.7736 | max(0.3, 1 − 0.35·core) |
| Total Escape | 0.4343 | ε + escCore · feedback |
| B = Capture / Escape | 2.61 | 1.131 / 0.434 |
Scoring Rationale
Parameter Sensitivity
MARGINAL B-INDEX CHANGE PER ±1 SCORE SHIFT
CLOSE7+0.74
PORT4-0.33
SUB4-0.33
ACT5+0.32
FALL5-0.29
DATA7+0.27
MEM7+0.27
PROC7+0.27
NET6+0.20
ORG8+0.19
MOM5+0.14
+ raises B (deepens lock-in)− lowers B (aids escape)
Comparable Platforms — Pharma & Biotech (10 peers)
| # | Platform | Ticker | B-index | Zone | |
|---|---|---|---|---|---|
| 01 | Illumina | ILMN | 5.78 | BLACK HOLE | Profile → |
| 02 | IQVIA | IQV | 5.18 | BLACK HOLE | Profile → |
| 03 | Thermo Fisher | TMO | 4.38 | BLACK HOLE | Profile → |
| 04 | Veeva Systems | VEEV | 3.88 | BLACK HOLE | Profile → |
| 05 | Roche | ROG.SW | 3.88 | BLACK HOLE | Profile → |
| 06 | Eli Lilly | LLY | 2.81 | BLACK HOLE | Profile → |
| 07 | AstraZeneca | AZN | 2.57 | BLACK HOLE | Profile → |
| 08 | Johnson and Johnson | JNJ | 2.53 | BLACK HOLE | Profile → |
| 09 | Moderna | MRNA | 1.86 | EVENT HORIZON | Profile → |
| 10 | Pfizer | PFE | 1.82 | EVENT HORIZON | Profile → |